XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 111 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,000 | -5.3% | 300,000 | +33.3% | 0.14% | -21.2% |
| Q2 2023 | $589,500 | -9.6% | 225,000 | -43.8% | 0.18% | -29.2% |
| Q1 2023 | $652,000 | +122456.4% | 400,000 | 0.0% | 0.25% | +42.9% |
| Q4 2022 | $532 | -99.9% | 400,000 | 0.0% | 0.18% | +21.2% |
| Q3 2022 | $624,000 | +15.8% | 400,000 | +14.3% | 0.15% | +7.4% |
| Q2 2022 | $539,000 | -66.7% | 350,000 | -44.7% | 0.14% | -32.3% |
| Q1 2022 | $1,620,000 | +87.5% | 633,040 | +114.6% | 0.20% | +58.3% |
| Q4 2021 | $864,000 | – | 295,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
| Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
| MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
| Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
| EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
| DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
| Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
| Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
| IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |